MIT engineers create nanoparticles for cancer vaccines
The gist
MIT researchers built a nanoparticle vaccine from a modified M13 bacteriophage that curbed tumors in mice.
The modular design could let vaccines be tailored to individual patients' tumors.
How it unfolded
- Oct 29, 2026EurekAlert!'s cancer research news release feed lists the MIT nanoparticle cancer vaccine release.
- Oct 30, 2026MIT News publishes Anne Trafton's article describing the nanoscale particle as a customizable delivery vehicle for personalized cancer vaccines.
- Oct 30, 2026Reports say a vaccine with 35 percent antigen density was the most protective of two tested in mice, which were much less likely to develop tumors when later exposed to melanoma cells; controlling antigen density also prevented colon tumors in mice.